Y502-3888
Y502-3888 is a c-Myc inhibitor. Y502-3888 binds to the c-Myc G4 structure, inhibits c-Myc transcription, and downregulates c-Myc expression at both mRNA and protein levels. Y502-3888 inhibits the viability of myeloma cells and induces cell apoptosis. Y502-3888 can be used for the research of multiple myeloma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 828292-11-1
- Formel: C19H18N6O3S
- Molecular Weight:410.45
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Y502-3888 (1-30 μM; 48 h) potently and selectively inhibits the viability of human multiple myeloma RPMI 8226 and U266 cells, with IC50 values of 12.67 μM and 7.03 μM, respectively, and minimal toxicity to non-malignant HEK293T cells[1].
Y502-3888 (5-20 μM; 48 h) dose-dependently induces apoptosis in human multiple myeloma U266 cells, with increasing proportions of early and late apoptotic cells at concentrations of 5, 10, and 20 μM[1].
Y502-3888 (5-20 μM; 48 h) dose-dependently downregulates c-Myc protein expression in human multiple myeloma U266 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human multiple myeloma U266 cells
-
Concentration:5, 10 and 20 μM
-
Incubation Time:48 h
-
Result:Induced dose-dependent increases in apoptotic cell populations.Resulted in 8.68% early apoptotic and 15.4% late apoptotic cells at 5 μM.
Resulted in 16.2% early apoptotic and 26.2% late apoptotic cells at 10 μM.
Resulted in 24.9% early apoptotic and 57.0% late apoptotic cells at 20 μM.
-
Cell Line:Human multiple myeloma U266 cells
-
Concentration:5, 10 and 20 μM
-
Incubation Time:48 h
-
Result:Reduced c-Myc protein levels in a dose-dependent manner.
Caused statistically significant reductions in c-Myc protein levels at 10 μM and 20 μM relative to control cells.
Markedly decreased c-Myc protein levels at 20 μM.
-
Cell Line:Human multiple myeloma U266 cells, CA46 Burkitt's lymphoma cells
-
Concentration:5, 10 and 20 μM
-
Incubation Time:48 h
-
Result:Reduced c-Myc mRNA levels in U266 cells in a dose-dependent manner, with expression reduced to ~50% of control at 20 μM.
Dose-dependently suppressed Exon 1 c-Myc mRNA levels in CA46 cells, with minimal effect on Exon 2 levels.
Chemical Information
-
CAS. Nr. 828292-11-1
-
Molecular Weight 410.45
-
Formel C19H18N6O3S
-
SMILES
CCN(C(C1=C(C2=C(S1)N=CN3N=C(N=C23)C4=CC=CC=C4[N+]([O-])=O)C)=O)CC
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Y502-3888 Related Classifications
HY-181234 Related Classifications
Powered by Bioz